Reports for RANBAXY PHARMACEUTICALS CANADA INC.

Company Name

RANBAXY PHARMACEUTICALS CANADA INC.

Totals

Shortage reports

72

Actual shortage: 4 (6%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 68 (94%)

Discontinuation Reports

32

To be discontinued: 0 (0%)
Discontinued: 32 (100%)
Reversed: 0 (0%)

Late reports

47 (45%)

Overdue reports

4 (100%)

Showing 141 to 72 of 72

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RAN-METFORMIN 850MG TABLET Discontinued 2019-11-26 2019-11-26 99755
RAN-CITALO 20MG TABLET Discontinued 2020-03-07 2020-03-07 108124
RAN-CITALO 20MG TABLET Discontinued 2020-03-07 2020-03-07 108127
RAN-LISINOPRIL 5MG TABLET Discontinued 2020-05-27 2020-05-27 115803
RAN-LISINOPRIL 10MG TABLET Discontinued 2020-05-27 2020-05-27 115806
RAN-LISINOPRIL 5MG TABLET Discontinued 2021-12-07 2021-12-07 150671
RAN-LISINOPRIL 20MG TABLET Discontinued 2021-12-07 2021-12-07 150674
RAN-OMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Discontinued 2017-07-21 2017-07-21 16588
RAN-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91278
RAN-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Discontinued 2019-08-09 2019-08-10 91281
RAN-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-02-02 2020-02-02 105096
RAN-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-03-07 2020-03-07 108130

Showing 21 to 32 of 32